World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
46
Citations
7064
World Ranking
6747
National Ranking
2921

Gerard B. Fox publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Gerard B. Fox sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 112 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Gerard B. Fox D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Gerard B. Fox sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 46 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Gerard B. Fox is affiliated with Georgetown University Medical Center in the United States. Their research spans several fields within medicine, with a notable focus on oncology, neurology, radiology, nuclear medicine, imaging, epidemiology, and economics and econometrics.

Their work covers a range of key topics, including:

  • HER2/EGFR in Cancer Research
  • Colorectal Cancer Treatments and Studies
  • Radiopharmaceutical Chemistry and Applications
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Acute Ischemic Stroke Management
  • Cinema and Media Studies

Recent publications by Gerard B. Fox highlight an interdisciplinary approach, reflected in work published between 2021 and 2024. These include:

  • "A Phase 1 and Biodistribution Study of ABT-806i, an 111In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806" (2021, Journal of Nuclear Medicine)
  • "Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion" (2023, Translational Stroke Research)
  • "Stim Cinema" (2024, Moving Image Review & Art Journal (MIRAJ))

The scientist has collaborated with several frequent co-authors, including Hui Gan, Matthew Burge, Benjamin Solomon, Sze Ting Lee, and Kyle D. Holen. This collaboration network spans the domains of medicine and media studies, complementing the diversity of research topics covered.

Gerard B. Fox's publications appear in journals that reflect a varied but focused academic interest, such as:

  • Journal of Nuclear Medicine
  • Translational Stroke Research
  • Moving Image Review & Art Journal (MIRAJ)

The combination of subfields and topics reveals a scientist engaged in both clinical and experimental research, particularly in areas related to cancer biology, neurological disorders including stroke and traumatic brain injury, and emerging intersections with media studies.

Best Publications

  • Activation of CPP32-Like Caspases Contributes to Neuronal Apoptosis and Neurological Dysfunction after Traumatic Brain Injury

    Alexander G. Yakovlev;Susan M. Knoblach;Lei Fan;Gerard B. Fox

  • Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

    Gerard B. Fox;Timothy A. Esbenshade;Jia Bao Pan;Richard J. Radek

  • Sustained Sensory/Motor and Cognitive Deficits With Neuronal Apoptosis Following Controlled Cortical Impact Brain Injury in the Mouse

    Gerard B. Fox;Lei Fan;Ryan A. Levasseur;Alan I. Faden

  • Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders.

    Timothy A Esbenshade;Gerard B Fox;Marlon D Cowart

  • Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup

    Gerard B Fox;Jia Bao Pan;Timothy A Esbenshade;Youssef L Bennani

  • Pharmacological Properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties

    Timothy A. Esbenshade;Gerard B. Fox;Kathleen M. Krueger;Thomas R. Miller

  • 4-(2-[2-(2(R)-Methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and Related 2-Aminoethylbenzofuran H3 Receptor Antagonists Potently Enhance Cognition and Attention

    Marlon Cowart;Ramin Faghih;Michael P. Curtis;Gregory A. Gfesser

  • Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization.

    Gerard B. Fox;Jia Bao Pan;Richard J. Radek;Angela M. Lewis

  • Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze.

    Gerard B. Fox;Lei Fan;Ryan A. LeVASSEUR;Alan I. Faden

  • Memory consolidation induces a transient and time-dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus.

    Gerard B. Fox;Alan W. O'Connell;Keith J. Murphy;Ciaran M. Regan

  • Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

    Timothy A. Esbenshade;Kathleen M. Krueger;Thomas R. Miller;Chae Hee Kang

  • Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.

    Timothy A Esbenshade;Gerard B Fox;Kathleen M Krueger;John L Baranowski

  • Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist.

    Arthur A. Hancock;Youssef L. Bennani;Eugene N. Bush;Timothy A. Esbenshade

  • Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

    Betty B. Yao;Gin Hsieh;Anthony V. Daza;Yihong Fan

  • Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan.

    Kaitlin E Browman;Victoria A Komater;Peter Curzon;Lynne E Rueter

  • The Behavioral Assessment of Sensorimotor Processes in the Mouse: Acoustic Startle, Sensory Gating, Locomotor Activity, Rotarod, and Beam Walking

    Peter Curzon;Min Zhang;Richard J. Radek;Gerard B. Fox

  • Antidepressant-like effect of D(2/3) receptor-, but not D(4) receptor-activation in the rat forced swim test.

    Ana M Basso;Kelly B Gallagher;Natalie A Bratcher;Jorge D Brioni

  • Default-mode-like network activation in awake rodents.

    Jaymin Upadhyay;Scott J. Baker;Prasant Chandran;Loan Miller

  • Awake rat pharmacological magnetic resonance imaging as a translational pharmacodynamic biomarker: metabotropic glutamate 2/3 agonist modulation of ketamine-induced blood oxygenation level dependence signals.

    Chih-Liang Chin;Jaymin Upadhyay;Gerard J Marek;Scott J Baker

  • H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization

    Victoria A. Komater;Kaitlin E. Browman;Peter Curzon;Arthur A. Hancock

  • Preclinical Characterization of A‐582941: A Novel α7 Neuronal Nicotinic Receptor Agonist with Broad Spectrum Cognition‐Enhancing Properties

    Karin R. Tietje;David J. Anderson;R. Scott Bitner;Eric A. Blomme

  • Perspectives on cognitive domains, H3 receptor ligands and neurological disease

    Arthur A Hancock;Gerard B Fox

Frequent Co-Authors

Michael W. Decker
Michael W. Decker Abbott (United Kingdom)
Kennan C. Marsh
Kennan C. Marsh AbbVie (United States)
Mark L. Day
Mark L. Day University of Michigan–Ann Arbor
Alan I. Faden
Alan I. Faden University of Maryland, Baltimore
Prisca Honore
Prisca Honore University of Minnesota
Steve McGaraughty
Steve McGaraughty AbbVie (United States)
Randall J. Bateman
Randall J. Bateman Washington University in St. Louis
Alan P. Kozikowski
Alan P. Kozikowski StarWise Therapeutics LLC
John Kelly
John Kelly University College London
David J. Anderson
David J. Anderson California Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gerard B. Fox

Trending Scientists